Comparing one vs two heat treatments for cervical precancer
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, more effective way to prevent cervical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 49 years old.
- You are living with HIV.
- You have a cervix (have not had a hysterectomy).
- You tested positive for high-risk HPV or had an abnormal VIA test within the last 3 months.
- You have not been treated for cervical precancer before.
- You are not currently pregnant or less than 6 weeks after giving birth.
- You are willing to come back to the clinic after 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, effective way to treat cervical precancer and prevent cancer.
This study compares using one versus two probes during a heat treatment (thermal ablation) for early cervical changes in women living with HIV. The goal is to see which approach is more feasible and effective, hopefully preventing cervical cancer.
This study tests whether using one or two heat probes works better to remove cervical precancer in women with HIV. Participants will get treatment at a clinic in Rwanda and be checked again after 6 months.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.